Furthermore, the complex action mechanism of NSCLC and the uncertain origins of FGFR1 mutations warrant further research to understand or determine FGFR1 signaling in LSCC pathophysiology. The gene discussed is FGFR1; the disease is non-small cell lung carcinoma.